Evaluation of the effect of different disease-modifying drugs on the retina and optic nerve in patients with multiple sclerosis
Journal of the Egyptian Ophthalmological Society · 2026-04 · 119 (2) · 201-208
DOI: 10.4103/ejos.ejos_69_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Egyptian Ophthalmological Society, online erschienen am 13.04.2026. Verfasst von Tasneem M.M. ElSadek und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To compare the effects of first-line disease-modifying drugs on protecting the retina and optic nerve in relapsing remitting multiple sclerosis patients using optical coherence tomography, optical coherence tomography angiography, and contrast sensitivity (CS).
Design
Cross-sectional study.
Participants
A total of 60 eyes of relapsing remitting multiple sclerosis patients attending Ain Shams University Hospital from September 2022 to June 2024. Patients and methods Patients were divided into three groups: receiving dimethyl fumarate (DMF), interferon β 1A or interferon β 1B. Optic nerve and macula were assessed at baseline, 3, and 6 months by measuring the peripapillary retinal nerve fiber layer (pRNFL) thickness, ganglion cell complex (GCC) thickness, macular thickness, peripapillary vessel density (VD), superficial and deep capillary plexuses VD and foveal avascular zone area. CS testing was also done.
Results
CS demonstrated an increase in all groups but was greater in the DMF group. Macular thickness was increased in all groups. The pRNFL remained stable in all groups. However, GCC showed the most significant mean reduction in the interferon β 1A group. The mean macular and optic disc VD parameters were not significantly changed among groups. There was a more significant correlation between the superficial capillary plexus VD and GCC thickness with CS than with the other parameters.
Conclusion
Disease-modifying drugs showed significant preservation of the visual function and neuronal structure as noted by improved CS (highest in the DMF group) and macular thickness, and stable GCC and pRNFL thickness. The superficial capillary plexus VD and GCC thickness seem to be better disease biomarkers for monitoring visual function.
Zitieren
APA
ElSadek, T. M., Mousa, A. S., Zaki, R. G., Abdelaziz, A. A., & Samak, N. M. (2026). Evaluation of the effect of different disease-modifying drugs on the retina and optic nerve in patients with multiple sclerosis. Journal of the Egyptian Ophthalmological Society, 119(2), 201-208. https://doi.org/10.4103/ejos.ejos_69_25
Vancouver
ElSadek TM, Mousa AS, Zaki RG, Abdelaziz AA, Samak NM. Evaluation of the effect of different disease-modifying drugs on the retina and optic nerve in patients with multiple sclerosis. Journal of the Egyptian Ophthalmological Society. 2026;119(2):201-208. doi:10.4103/ejos.ejos_69_25
BibTeX
@article{ElSadek2026,
author = {ElSadek, Tasneem M.M. and Mousa, Amr S.G. and Zaki, Rania G.E. and Abdelaziz, Azza A. and Samak, Noha M.},
title = {Evaluation of the effect of different disease-modifying drugs on the retina and optic nerve in patients with multiple sclerosis},
journal = {Journal of the Egyptian Ophthalmological Society},
year = {2026},
volume = {119},
number = {2},
pages = {201--208},
doi = {10.4103/ejos.ejos_69_25}
}
EUVIMED